CITY THERAPEUTICSPrice range
CITY THERAPEUTICS sets an IPO price range
CITY THERAPEUTICS sets an IPO price range (October 9, 2026).
CITY THERAPEUTICS is a clinical-stage biotechnology company developing RNA interference therapeutics designed to silence disease-relevant proteins.
Offering details
- Price range
- $17.0 to $19.0
- Shares offered
- 9.7M
- Exchange
- Nasdaq Global Market
- Proposed ticker
- CTY